Board approves capital reduction, new director, and AGM notice
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samsrita Labs board on 4 July 2026 approved a capital reduction scheme to cancel about 1.13 crore equity shares on a pro-rata basis, cutting paid-up equity capital from Rs 22.75 crore to Rs 11.37 crore. Purpose is to set off Rs 11.37 crore of accumulated losses and wipe out the share premium balance. Shareholding percentages will remain unchanged for all shareholders. Board also appointed Mr. Ravikanth Chopperla as Additional Non-Executive Director; he holds 7.1 percent stake and is Executive Director and COO of associate company QROPS Advisory. Board approved entering into related party transactions with QROPS Advisory, added pet animal healthcare to main objects, and fixed AGM for 10 August 2026.
Capital cut is technically neutral for shareholders (percentages unchanged) but reveals sizeable past losses. New director and related party deal with his own firm QROPS Advisory raise governance concerns worth tracking.